IP Library › Assignment 054920/0739
Patent Assignment
Reel/Frame 054920/0739

Change of Name

Recorded: 2021-01-07 Pages: 5
Assignor
PORTOLA PHARMACEUTICALS, INC.
Executed: 2020-10-15
Assignee
PORTOLA PHARMACEUTICALS, LLC
270 E. GRAND AVE., SOUTH SAN FRANCISCO, CALIFORNIA, 94080
Covered Properties (62)
Antidotes for Factor Xa Inhibitors and Methods of Using the Same in Combination with Blood Coagulating Agents
Application: 61/114,948 →
Antidotes for Factor Xa Inhibitors and Methods of Using the Same in Combination with Blood Coagulating Agents
Patent: 8,455,439 →
Application: 12/616,735 →
Publication: US US20100125052A1
Antidotes for Factor Xa Inhibitors and Methods of Using the Same in Combination with Blood Coagulating Agents
Application: 13/874,313 →
Publication: US US20140134151A1
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 61/164,886 →
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Patent: 8,268,783 →
Application: 12/749,217 →
Publication: US US20100255000A1
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Patent: 9,109,046 →
Application: 13/591,098 →
Publication: US US20130129693A1
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Patent: 9,587,233 →
Application: 14/790,305 →
Publication: US US20160002617A1
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 15/435,086 →
Publication: US US20170233711A1
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 16/250,870 →
Publication: US US20190309279A1
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 61/225,887 →
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Patent: 9,056,106 →
Application: 12/836,536 →
Publication: US US20110015128A1
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 14/320,199 →
Publication: US US20150025011A1
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 15/212,105 →
Publication: US US20170014492A1
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 15/833,520 →
Publication: US US20180236049A1
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Application: 16/943,933 →
Publication: US US20210085762A1
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Application: 61/598,694 →
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Application: 13/766,652 →
Publication: US US20130230901A1
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Application: 14/745,901 →
Publication: US US20150376592A1
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Application: 15/391,020 →
Publication: US US20170240879A1
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Application: 16/127,864 →
Publication: US US20190127720A1
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
Application: 61/599,821 →
Modulation of Factor Xa Inhibitor-Mediated Blood Loss by Partial and Transient Administration of Antidote
Application: 61/682,615 →
Modulation of Factor Xa Inhibitor-Mediated Blood Loss by Partial and Transient Administration of Antidote
Application: 61/734,269 →
MODULATION OF FACTOR Xa INHIBITOR MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
Application: 61/756,842 →
Modulation of Factor Xa Inhibitor Mediated Blood Loss by Partial and Transient Administration of Antidote
Application: 61/759,571 →
Modulation of Factor Xa Inhibitor Mediated Blood Loss by Partial and Transient Administration of Antidote
Application: 14/378,440 →
Publication: US US20160015793A1
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
Application: 15/902,886 →
Publication: US US20180185459A1
MODULATION OF FACTOR Xa INHIBITOR-MEDIATED BLOOD LOSS BY PARTIAL AND TRANSIENT ADMINISTRATION OF ANTIDOTE
Application: 16/519,732 →
Publication: US US20200129597A1
Method for Purification of Recombinant Factor Xa Derivatives
Application: 61/659,821 →
Method for Purification of Recombinant Factor Xa Derivatives
Application: 14/406,645 →
Publication: US US20150239929A1
Compounds and Methods for Purification of Serine Proteases
Application: 61/746,544 →
Compounds and Methods for Purification of Serine Proteases
Patent: 9,200,268 →
Application: 13/830,372 →
Publication: US US20140186923A1
Compounds and Methods for Purification of Serine Proteases
Application: 14/142,655 →
Publication: US US20140346397A1
Compounds and Methods for Purification of Serine Proteases
Patent: 9,644,195 →
Application: 14/723,395 →
Publication: US US20150337285A1
INHIBITION OF TISSUE FACTOR PATHWAY INHIBITOR WITH FACTOR Xa DERIVATIVES
Application: 61/756,359 →
Inhibition of Tissue Factor Pathway Inhibitor with Factor Xa Derivatives
Application: 14/762,098 →
Publication: US US20150352194A1
Inhibition of Tissue Factor Pathway Inhibitor with Factor Xa Derivatives
Application: 15/919,014 →
Publication: US US20180333469A1
Lyophilized Formulations for Factor Xa Antidote
Application: 62/039,809 →
Lyophilized Formulations for Factor Xa Antidote
Application: 15/136,810 →
Publication: US US20160237420A1
Lyophilized Formulations for Factor Xa Antidote
Application: 15/820,265 →
Publication: US US20180320160A1
Lyophilized Formulations for Factor Xa Antidote
Application: 16/895,443 →
Publication: US US20200299667A1
Lyophilized Formulations for Factor Xa Antidote
Application: 16/895,448 →
Publication: US US20200299668A1
Antidotes to Factor Xa Inhibitors
Application: 62/686,968 →
Antidotes to Factor Xa Inhibitors
Application: 17/254,146 →
Publication: US US20210371842A1
Lyophilized Formulations for Factor Xa Antidote
Application: 62/299,369 →
Lyophilized Formulations for Factor Xa Antidote
Application: 16/078,596 →
Publication: US US20190046450A1
Preparation of Factor Xa Derivatives
Application: 62/351,841 →
Preparation of Factor Xa Derivatives
Application: 15/626,813 →
Publication: US US20170369862A1
Preparation of Factor Xa Derivatives
Application: 16/740,001 →
Publication: US US20200208131A1
Methods for Treating Intracranial Hemorrhage and Assessing Efficacy
Application: 62/802,645 →
Compositions and Methods for Preparing Factor Xa and Derivatives
Application: 62/884,652 →
Compositions and Methods for Preparing Factor Xa and Derivatives
Application: 62/990,885 →
Methods for Testing Andexanet Potency
Application: 63/039,795 →
Antidotes for Factor Xa Inhibitors and Methods of Using the Same in Combination with Blood Coagulating Agents
Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Unit Dose Formulation of Antidotes for Factor Xa Inhibitors and Methods of Using the Same
Process for Making Recombinant Antidote to Factor Xa Inhibitor
Compounds and Methods for Purification of Serine Proteases
Lyophilized Formulations for Factor Xa Antidote
Preparation of Factor Xa Derivatives
Methods for Treating Intracranial Hemorrhage and Assessing Efficacy
Compositions and Methods for Preparing Factor Xa and Derivatives
Related Assignments (25)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Jan 26, 2009
From: LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 022157/0206 →
Assignment of Assignor's Interest Aug 19, 2009
From: SINHA, UMA; LU, GENMIN; CONLEY, PAMELA B.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023118/0550 →
Assignment of Assignor's Interest Sep 22, 2009
From: SINHA, UMA; LU, GENMIN; HUTCHALEELAHA, ATHIWAT; HOLLENBACH, STANLEY J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023268/0443 →
Assignment of Assignor's Interest Jan 13, 2010
From: LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 023779/0904 →
Assignment of Assignor's Interest Jun 14, 2010
From: SINHA, UMA; LU, GENMIN; CONLEY, PAMELA B.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 024533/0407 →
Assignment of Assignor's Interest Sep 21, 2010
From: SINHA, UMA; LU, GENMIN; HUTCHALEELAHA, ATHIWAT; HOLLENBACH, STANLEY J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 025024/0354 →
Assignment of Assignor's Interest Nov 29, 2012
From: HOLLENBACH, STANLEY J.; LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 029376/0281 →
Assignment of Assignor's Interest Nov 29, 2012
From: HOLLENBACH, STANLEY J.; LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 029376/0384 →
Assignment of Assignor's Interest Dec 19, 2012
From: SINHA, UMA; LU, GENMIN; CONLEY, PAMELA B.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 029503/0988 →
Assignment of Assignor's Interest Jan 29, 2013
From: LU, GENMIN; CONLEY, PAMELA B.; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 029716/0158 →
Assignment of Assignor's Interest Mar 21, 2013
From: LU, GENMIN; CONLEY, PAMELA B.; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030061/0256 →
Assignment of Assignor's Interest Mar 21, 2013
From: HOLLENBACH, STANLEY J.; LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030060/0534 →
Assignment of Assignor's Interest Mar 21, 2013
From: HOLLENBACH, STANLEY J.; LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030060/0844 →
Assignment of Assignor's Interest Mar 21, 2013
From: HOLLENBACH, STANLEY J.; LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030060/0669 →
Assignment of Assignor's Interest May 1, 2013
From: LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 030326/0513 →
Assignment of Assignor's Interest Nov 13, 2014
From: SINHA, UMA; LU, GENMIN; HUTCHALEELAHA, ATHIWAT; HOLLENBACH, STANLEY J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 034168/0123 →
Assignment of Assignor's Interest Jan 8, 2015
From: HOLLENBACH, STANLEY J.; LU, GENMIN; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 034668/0332 →
Assignment of Assignor's Interest Jul 2, 2015
From: SINHA, UMA; LU, GENMIN; CONLEY, PAMELA B.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 035971/0427 →
Assignment of Assignor's Interest Sep 10, 2015
From: LU, GENMIN; CONLEY, PAMELA B.; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 036531/0779 →
Assignment of Assignor's Interest Aug 4, 2016
From: SINHA, UMA; LU, GENMIN; HUTCHALEELAHA, ATHIWAT; HOLLENBACH, STANLEY J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 039341/0673 →
Assignment of Assignor's Interest Apr 4, 2017
From: LU, GENMIN; CONLEY, PAMELA B.; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 041849/0008 →
Assignment of Assignor's Interest May 9, 2017
From: SINHA, UMA; LU, GENMIN; CONLEY, PAMELA B.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 042304/0156 →
Assignment of Assignor's Interest Jan 25, 2018
From: SINHA, UMA; LU, GENMIN; HUTCHALEELAHA, ATHIWAT; HOLLENBACH, STANLEY J.
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 044733/0428 →
Assignment of Assignor's Interest Nov 9, 2018
From: LU, GENMIN; CONLEY, PAMELA B.; SINHA, UMA
To: PORTOLA PHARMACEUTICALS, INC.
Reel/Frame 047462/0711 →
Security Interest Mar 18, 2019
From: PORTOLA PHARMACEUTICALS, INC.
To: HCR COLLATERAL MANAGEMENT, LLC
Reel/Frame 048633/0673 →